There is a continuous search for more reliable.
Introduction
Tissue fluorescence following intravenous injection of sodium fluorescein has been used for many years as a visual indicator of capillary blood flow. It has been used in limbs compromised by peripheral vascular disease and in other tissues whose viability was compromised by acute 'and chronic ischaemia (Lange and Boyd, 1942..and 1944; Myers. 1962 ). The dye is distributed throughout the patent vascular system. It diffuses through the capillary walls to equilibrate with the extracellular fluid. Exposure of skin or tissue surfaces to blue or ultraviolet light produces a yellow-green fluorescence. Hypoperfusion is presumed in absence of fluorescence .
Estimation of the degree of fluorescence by the naked eye is not accurate and means of All correspondence to be addressed to Dr The fibreoptic dermofluorometer has been developed by Silverman et al, (1980) and the Johnson Research Foundation. The present perfusion fluorometer is manufactured by Diversatronics, Inc., Broomall, Pennsylvania, U.S.A.
Action of the perfusion dermofluorometer
Incandescent light passes through an excitation filter which selectively transmits wavelengths between 450 and 500 nanometers, within the range of maximal excitation of fluorescein in vivo (Delori et al, 1978) . This light passes along fibreoptic pathways to the probe which is held on the tissues being tested. The probe also contains fibreoptic bundles which carry the emitted fluorescence plus reflected excitation light back to the instrument. Both fluorescent emissions and reflected excitation light pass through a selective filter before reaching the photo multiplier tube. This filter passes wavelengths between 530 and 660 nanometers. With such selective transmission there is minimal overlap and a resultant high signal to noise ratio. There are two photo multiplier tubes which allow for simultaneous 69 measurements of experimental and control areas. The emitted fluorescence is quantified by the photo multiplier tube and is read as DF (dye fluorescence) on an arbitary scale.
Tissue uptake of fluorescein appears to be a multiexponential function which can be empirically converted to a "straight line" by graphing "DF readings vs. log time." The slope of this line provides an index of fluorescein uptake (IFU). 1. Patients will be randomly assigned to control or treatment groups. In the control group the surgeon will not be shown the perfusion results. Amputation will be carried out at the level determined by the hospitals "standard" means of assessment (Wagner, 1979) . In the treatment group amputation will be performed at the level determined by the test showing the greatest amount of limb salvage. Successes and failures will be analysed by standard statistical methods.
Most articles report virtually no complications. However, a recent review of the literature reports two cardiac arrests and three fatal reactions (Buchanan and Levine, 1982) . The same authors report a study on 38 flap procedures in 29 patients over a ten year period. An immediate blood pressure drop of more than 20 mmHg was noted on nine occasions. Pressure returned to base line with supportive measures in six patients, but ephedrine was felt to be necessary on three occasions.
The only side effect seen so far in our patients has been mild nausea.
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Summary
Tissue fluorescence has been used to aid in determining nutritive blood flow. Quantification of fluorescence by the naked eye has not been accurate. Previous instruments to measure fluorescein dynamics were not acceptable for clinical use due to cumbersome size.
A new fibreoptic perfusion fluorometer has been developed that contains the basic elements of earlier instruments but removes the bulky components from the patient. The probe is placed on the area to be examined after fluorescein injection and a reading is obtained in one second.
Preliminary studies in animals and in humans show that ultimate viability of tissue can be predicted and amputation level selected with great reliability.
